CorMedix Inc. (CRMD) shares climbed 6.88 percent to $11.96 on Wednesday after the company reported a sharp turnaround to profit in the third quarter.
A year prior, the biopharmaceutical company reported a net loss of $2.8 million, or $0.05 per share, while this year it reported a net income of $108.6 million, or $1.26 per share. Due to a sharp increase in product sales to $101.5 million, revenue increased from $11.5 million to $104.3 million.
With a volume of 5.4 million shares, the stock fluctuated between $10.75 and $12.89 from its opening price of $11.75 to an average of 3.2 million shares on the Nasdaq. Over the previous 52 weeks, CorMedix has fluctuated between $5.60 and $17.43.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.